ALLMedicine™ Lung Cancer Chemotherapy Center
Research & Reviews 35 results
Medicine Li H, Liu H
Oct 23rd, 2021 - Increasing attention has been paid to acupuncture and auricular acupressure as alternative strategies for cancer related fatigue (CRF) management. Therefore, we design this systematic review and meta-analysis to explore the efficacy and safety of ...
Lung Cancer (Amsterdam, Netherlands); Mody GN, Stover AM et. al.
Oct 12th, 2021 - Patients with lung cancer have high symptom burden and diminished quality of life. Electronic patient-reported outcome (PRO) platforms deliver repeated longitudinal surveys via web or telephone to patients and alert clinicians about concerning sym...
Drug Delivery; Yu XY, Jin X et. al.
Sep 28th, 2021 - Lung cancer is the second most common and lethal cancer in the world. Chemotherapy is the preferred treatment modality for lung cancer and prolongs patient survival by effective controlling of tumor growth. However, owing to the nonspecific delive...
Oncology Reports; Zeng T, Xu M et. al.
Jun 4th, 2021 - Multidrug resistance (MDR) is one of the major reasons for the clinical failure of cancer chemotherapy. Autophagy activation serves a crucial role in MDR. However, the specific molecular mechanism linking autophagy with MDR remains unknown. The re...
The American Journal of Nursing; Aschenbrenner DS
May 20th, 2021 - Trilaciclib (Cosela) is approved to protect normal bone marrow cells from damage secondary to chemotherapy in adults receiving a platinum-etoposide chemotherapy regimen or a topotecan chemotherapy regimen for extensive-stage small cell lung cancer.